Wakamoto Pharmaceutical
4512.T
#10218
Rank
โ‚ฌ50.11 M
Marketcap
1,44ย โ‚ฌ
Share price
1.15%
Change (1 day)
-17.95%
Change (1 year)

Revenue for Wakamoto Pharmaceutical (4512.T)

Revenue in 2023: โ‚ฌ51.14 Million

According to Wakamoto Pharmaceutical's latest financial reports the company's current revenue (TTM ) is โ‚ฌ45.68 Million. In 2023 the company made a revenue of โ‚ฌ51.14 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ58.96 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Wakamoto Pharmaceutical from 2009 to 2023

Annual revenue

Year Revenue Change
2023โ‚ฌ51.14 M-13.26%
2022โ‚ฌ58.96 M-11.76%
2021โ‚ฌ66.82 M-4.37%
2020โ‚ฌ69.87 M-23.39%
2019โ‚ฌ91.21 M8.51%
2018โ‚ฌ84.05 M4.03%
2017โ‚ฌ80.8 M-16.15%
2016โ‚ฌ96.35 M13.9%
2015โ‚ฌ84.59 M5.26%
2014โ‚ฌ80.37 M5.77%
2013โ‚ฌ75.98 M-14%
2012โ‚ฌ88.36 M-5.88%
2011โ‚ฌ93.88 M13.6%
2010โ‚ฌ82.64 M13.37%
2009โ‚ฌ72.9 M